Complex roles of cAMP–PKA–CREB signaling in cancer

被引:0
作者
Hongying Zhang
Qingbin Kong
Jiao Wang
Yangfu Jiang
Hui Hua
机构
[1] Sichuan University,Laboratory of Oncogene, National Clinical Research Center for Geriatrics, West China Hospital
[2] Chengdu University of Traditional Chinese Medicine,School of Basic Medicine
[3] Sichuan University,Laboratory of Stem Cell Biology, West China Hospital
来源
Experimental Hematology & Oncology | / 9卷
关键词
cAMP; PKA; CREB; Cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Cyclic adenosine monophosphate (cAMP) is the first discovered second messenger, which plays pivotal roles in cell signaling, and regulates many physiological and pathological processes. cAMP can regulate the transcription of various target genes, mainly through protein kinase A (PKA) and its downstream effectors such as cAMP-responsive element binding protein (CREB). In addition, PKA can phosphorylate many kinases such as Raf, GSK3 and FAK. Aberrant cAMP–PKA signaling is involved in various types of human tumors. Especially, cAMP signaling may have both tumor-suppressive and tumor-promoting roles depending on the tumor types and context. cAMP–PKA signaling can regulate cancer cell growth, migration, invasion and metabolism. This review highlights the important roles of cAMP–PKA–CREB signaling in tumorigenesis. The potential strategies to target this pathway for cancer therapy are also discussed.
引用
收藏
相关论文
共 737 条
  • [1] Braun TP(2020)Response and resistance to BCR–ABL1-targeted therapies Cancer Cell 37 530-542
  • [2] Eide CA(2019)Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy J Hematol Oncol 12 134-196
  • [3] Druker BJ(2019)Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors incancer therapy J Hematol Oncol 12 27-458
  • [4] Lim ZF(2018)Molecular targeted therapy: treating cancer with specificity Eur J Pharmacol 834 188-4067
  • [5] Ma PC(2019)Targeting mTOR for cancer therapy J Hematol Oncol 12 71-64
  • [6] Qin S(2014)The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment Cancers 6 436-1912
  • [7] Li A(2012)The cyclic AMP pathway Cold Spring Harb Perspect Biol 4 a011148-354
  • [8] Yi M(2020)What turns CREB on? And off? And why does it matter? Cell Mol Life Sci 77 4049-41
  • [9] Yu S(2002)Reinventing the wheel of cyclic AMP: novel mechanisms of cAMP signaling Ann NY Acad Sci 968 49-3732
  • [10] Zhang M(2013)Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose- and hormone-stimulated insulin secretion Diabetes 62 1904-15926